Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Generation Bio Q2 EPS $(0.31) Misses $(0.28) Estimate, Sales $4.09M Beat $1.96M Estimate

Author: Benzinga Newsdesk | August 07, 2024 04:47pm
Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.28) by 10.71 percent. This is a 34.04 percent increase over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $4.09 million which beat the analyst consensus estimate of $1.96 million by 108.72 percent. This is a 364.89 percent increase over sales of $880.00 thousand the same period last year.

Posted In: GBIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist